Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatobiliary Disease”

2,986 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,986 results

Testing effectiveness (Phase 2)Study completedNCT03976401
What this trial is testing

Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc 110
Not applicableNo Longer AvailableNCT02477345
What this trial is testing

Compassionate Use of Omegaven IV Fat Emulsion

Who this might be right for
CholestasisLiver Disease
Northwell Health
Not applicableWithdrawnNCT03302481
What this trial is testing

Mitochondrial Metabolism and Hepatic Complications of Obesity

Who this might be right for
Obesity
Nantes University Hospital
Not applicableStudy completedNCT00005657
What this trial is testing

Genetics of Hepatitis C Virus Infection

Who this might be right for
Hepatitis CLiver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 870
Not applicableUnknownNCT03474328
What this trial is testing

AlcoChange: An Open Label Pilot Study of Smartphone Monitoring for Alcoholic Liver Disease

Who this might be right for
Alcohol-Related Disorders
Royal Free Hospital NHS Foundation Trust 60
Large-scale testing (Phase 3)Study completedNCT02535195
What this trial is testing

Effect of Ginger Supplement on Non-alcoholic Fatty Liver

Who this might be right for
Non-alcoholic Fatty Liver Disease
Dr Azita Hekmatdoost 60
Post-approval studies (Phase 4)Ended earlyNCT04973007
What this trial is testing

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

Who this might be right for
Oligometastatic DiseaseLiver MetastasesColorectal Cancer
University of Colorado, Denver 10
Not applicableStudy completedNCT03942822
What this trial is testing

Chia Supplementation and Non Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDietary Modification
Instituto Nacional de Cardiologia Ignacio Chavez 40
Not applicableStudy completedNCT02859753
What this trial is testing

Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation

Who this might be right for
ThermoablationChronic Liver DiseaseHepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 35
Large-scale testing (Phase 3)Study completedNCT00006164
What this trial is testing

Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment

Who this might be right for
Chronic Hepatitis cCirrhosis, LiverFibrosis, Liver+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,050
Not applicableUnknownNCT01927133
What this trial is testing

LIVER FIBROSIS PREVALENCE IN FRANCE

Who this might be right for
Liver Fibrosis Progression in Chronic Liver Disease
Assistance Publique - Hôpitaux de Paris 10,000
Not applicableStudy completedNCT06980571
What this trial is testing

Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections

Who this might be right for
Liver Disease
Barts & The London NHS Trust 100
Not applicableWithdrawnNCT01314508
What this trial is testing

Increlex Treatment of Children With Chronic Liver Disease and Short Stature

Who this might be right for
Growth FailureChronic Liver Disease
University of California, Los Angeles
Not applicableUnknownNCT05422092
What this trial is testing

Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03867487
What this trial is testing

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNAFLDPediatric NAFLD
Justin Ryder 40
Not applicableLooking for participantsNCT06777914
What this trial is testing

Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers

Who this might be right for
Hepatobiliary CancersProgressive Familial Intrahepatic Cholestasis (PFIC)Cholestatic Liver Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna 600
Not applicableUnknownNCT05215964
What this trial is testing

The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney DiseasesPolycystic Liver DiseaseMuscle Loss
National Taiwan University Hospital 600
Not applicableLooking for participantsNCT06863012
What this trial is testing

EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG

Who this might be right for
Portal HypertensionChronic Liver Disease (CLD)Cirrhosis
Fundacio Privada Mon Clinic Barcelona 20
Not applicableLooking for participantsNCT00345930
What this trial is testing

DILIN - Prospective Study

Who this might be right for
Liver Diseases
Duke University 4,000
Testing effectiveness (Phase 2)Study completedNCT00249652
What this trial is testing

Transplant and Addiction Project (TAP) - 1

Who this might be right for
End Stage Liver DiseaseEnd Stage Renal DiseaseSubstance-Related Disorders
St. Luke's-Roosevelt Hospital Center 41
Load More Results